2011•Zhongguo redai yixueRequires access

Clinical distribution and drug resistance of 159 Enterobacter cloacae strains

Lin Feng

Open publisher page 0 citations

Abstract

Objective To survey the clinical distribution and drug resistance of 159 Enterobacter cloacae strains Methods During 2007~2009,159 clinical strains of Enterobacter cloacae were isolated from the patients and the clinical distribution and drug resistance were surveyed.Results The 159 clinical Enterobacter cloacae strains were isolated from the sputum and wound secretion.The clinical strains of Enterobacter cloacae were high resistant to the penicillin G,followed by the second generation cephalosporin;the resistant to the third and the fourth generation cephalosporin increased year by year.The resistannce rates to the tebipenem pivoxil and aminoglycoside were low.Conclusion The clinically isolation rate and the resistance degree of Enterobacter cloacae to antibiotics increased year by year.The resistance of Enterobacter cloacae be detected for guiding the rational use of antibiotics.

About this research paper

What this paper is about

Objective To survey the clinical distribution and drug resistance of 159 Enterobacter cloacae strains Methods During 2007~2009,159 clinical strains of Enterobacter cloacae were isolated from the patients and the clinical distribution and drug resistance were surveyed.Results The 159 clinical Enterobacter cloacae strains were isolated from the sputum and wound secretion.The clinical strains of Enterobacter cloacae were high resistant to the penicillin G,followed by the second generation cephalosporin;the resistant to the third and the fourth generation cephalosporin increased year by year.The resistannce rates to the tebipenem pivoxil and aminoglycoside were low.Conclusion The clinically isolation rate and the resistance degree of Enterobacter cloacae to antibiotics increased year by year.The resistance of Enterobacter cloacae be detected for guiding the rational use of antibiotics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To survey the clinical distribution and drug resistance of 159 Enterobacter cloacae strains Methods During 2007~2009,159 clinical strains of Enterobacter cloacae were isolated from the patients and the clinical distribution and drug resistance were surveyed.Results The 159 clinical Enterobacter cloacae strains were isolated from the sputum and wound secretion.The clinical strains of Enterobacter cloacae were high resistant to the penicillin G,followed by the second generation cephalosporin;the resistant to the third and the fourth generation cephalosporin increased year by year.The resistannce rates to the tebipenem pivoxil and aminoglycoside were low.Conclusion The clinically isolation rate and the resistance degree of Enterobacter cloacae to antibiotics increased year by year.The resistance of Enterobacter cloacae be detected for guiding the rational use of antibiotics.

Key concepts: Enterobacter cloacae, Cephalosporin, Microbiology, Enterobacter, Penicillin, Antibiotics, Drug resistance, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical distribution and drug resistance of 159 Enterobacter cloacae strains — Research Paper | ScholarLens